Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Intensity of Microsporidia spores among HIV-infected patients and their Non-HIV-infected counterparts in a Tertiary Hospital in Nigeria.

View through CrossRef
Background: Microsporidia infection still remains a public health challenge in immuno-compromised subjects particularly in developing countries. Objective: A study was carried out among HIV-infected patients at a University of Ilorin Teaching Hospital in Nigeria to determine the prevalence and intensity of microsporidiasis. Methods: Seven hundred and fifty stool samples were collected from HIV-infected patients and 375 samples from their non-infected counterparts matched for age, sex and socio-economic variables. Microsporidia species were characterized morphologically, using Chromoptrope 2R staining technique. Pure microsporidia spores were isolated from the stool samples by the Ficoll-Hipaque technique. The size of microsporidial were confirmed by the comparison with the reference specimen (No. UN3373) obtained from the Center for Disease Control and Prevention (CDC) Atlanta, USA. Results: The overall prevalence of microsporidia isolates in the stool samples of 750 HIV-infected patients was 42.4%. This infection rate was significantly higher than among the HIV-non-infected subjects (19.2%) (P<0.05). The intensity of microsporidia spores among HIV-infected patients (mean ± SD=176±52.3) was significantly higher than the intensity among the non-infected control group (mean ± SD=23±8.2) (P<0.05). This intensity spores among HIV-infected patients who were on HAART treatment and among those who were not on HAART treatment were similar. In general, the intensity of microsporidia spores by age, sex, marital status, occupation and education was significantly higher among HIV-infected patients than among their HIV-non-infected counterpart (P<0.05).  Conclusion: Microsporidiasis is prevalent among immuno-compromised (HIV/AIDS) patients with a very high intensity. Therefore, it is highly desirable that a drug of choice for the treatment of microsporidiasis should be developed. Health education campaigns to promote awareness, prevention and control of microsporidiasis should be mounted.
Title: Intensity of Microsporidia spores among HIV-infected patients and their Non-HIV-infected counterparts in a Tertiary Hospital in Nigeria.
Description:
Background: Microsporidia infection still remains a public health challenge in immuno-compromised subjects particularly in developing countries.
Objective: A study was carried out among HIV-infected patients at a University of Ilorin Teaching Hospital in Nigeria to determine the prevalence and intensity of microsporidiasis.
Methods: Seven hundred and fifty stool samples were collected from HIV-infected patients and 375 samples from their non-infected counterparts matched for age, sex and socio-economic variables.
Microsporidia species were characterized morphologically, using Chromoptrope 2R staining technique.
Pure microsporidia spores were isolated from the stool samples by the Ficoll-Hipaque technique.
The size of microsporidial were confirmed by the comparison with the reference specimen (No.
UN3373) obtained from the Center for Disease Control and Prevention (CDC) Atlanta, USA.
Results: The overall prevalence of microsporidia isolates in the stool samples of 750 HIV-infected patients was 42.
4%.
This infection rate was significantly higher than among the HIV-non-infected subjects (19.
2%) (P<0.
05).
The intensity of microsporidia spores among HIV-infected patients (mean ± SD=176±52.
3) was significantly higher than the intensity among the non-infected control group (mean ± SD=23±8.
2) (P<0.
05).
This intensity spores among HIV-infected patients who were on HAART treatment and among those who were not on HAART treatment were similar.
In general, the intensity of microsporidia spores by age, sex, marital status, occupation and education was significantly higher among HIV-infected patients than among their HIV-non-infected counterpart (P<0.
05).
 Conclusion: Microsporidiasis is prevalent among immuno-compromised (HIV/AIDS) patients with a very high intensity.
Therefore, it is highly desirable that a drug of choice for the treatment of microsporidiasis should be developed.
Health education campaigns to promote awareness, prevention and control of microsporidiasis should be mounted.

Related Results

HIV WGS - 400bp Amplicon Tiling - Oxford Nanopore Technology Protocol v1
HIV WGS - 400bp Amplicon Tiling - Oxford Nanopore Technology Protocol v1
OSPHL in collaboration with APHL, will evaluate the performance of the Oxford Nanopore Technology sequencers for HIV genome sequencing using a modified protocol of the ARTIC amplic...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract Introduction Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Determination of Microsporidia Infection in Larvae and Adult Anopheles Mosquitoes (Diptera: Culicidae) Northwest Ethiopia
Determination of Microsporidia Infection in Larvae and Adult Anopheles Mosquitoes (Diptera: Culicidae) Northwest Ethiopia
Abstract Background: Microsporidia are a diverse group of obligate intracellular, spore forming parasites that infect all phyla of invertebrates. Microsporidia are known to...
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
A infecção pelo vírus do HIV pode ocorrer de diversas maneiras, tendo sua principal forma a via sexual por meio do sexo desprotegido. O vírus do HIV fica em um período de incubação...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract Introduction Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Prevention of DNA damage in spores and in vitro by small, acid-soluble proteins from Bacillus species
Prevention of DNA damage in spores and in vitro by small, acid-soluble proteins from Bacillus species
The DNA in dormant spores of Bacillus species is saturated with a group of nonspecific DNA-binding proteins, termed alpha/beta-type small, acid-soluble spore proteins (SASP). These...
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Background: HIV rapid diagnosis in The Gambia is mainly done using Determine HIV-1/2 and First Response HIV 1.2.0 or SD Bioline HIV-1/2 3.0 for screening and sero-typing of HIV res...
Abstract 5594: Progression of paraproteinemia in HIV-positive versus HIV-negative patients
Abstract 5594: Progression of paraproteinemia in HIV-positive versus HIV-negative patients
Abstract BACKGROUND: Paraproteinemias occur in 1 to 3% of people over the age of 50 and progress to hematological malignancies (HM) at the rate of about 1% per year....

Back to Top